NATIONWIDE — THE U.S. FOOD AND DRUG ADMINISTRATION on Tuesday, May 6 announced it will expand unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines and other medical products intended for American consumers and patients. This change builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program in India and China and aims to ensure that foreign companies will receive the same level of regulatory oversight and scrutiny as domestic companies.
The FDA conducts approximately 12,000 domestic inspections and 3,000 foreign inspections annually in more than 90 countries. While U.S. manufacturers undergo frequent, unannounced inspections, foreign firms were often given weeks to prepare, undermining the integrity of the oversight process. Only in specific programs and cases are the FDA’s domestic inspections pre-announced to assure that appropriate records and personnel will be available during the inspection, but domestic companies still lack the authority to negotiate the day or time of the inspection.
NPR reported on April 18 that, although Health & Human Services Secretary Robert F. Kennedy, Jr. announced that thousands of health agencies were being cut back, he pledged to keep the inspectors who keep America’s food and drugs safe and already had plans to examine factories worldwide.
✰✰✰
